Upper Respiratory Tract Infection Treatment Market by Type and Geography - Forecast and Analysis 2020-2024

The upper respiratory tract infection treatment market size has the potential to grow by USD 1.79 billion during 2020-2024, and the market's growth momentum will accelerate during the forecast period.

This report provides a detailed analysis of the market by type (antibiotics, NSAIDs and nasal decongestants, and others) and geography (North America, Europe, Asia, and ROW). Also, the report analyzes the market's competitive landscape and offers information on several market vendors, including AstraZeneca Plc, CSL Ltd., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi, and Teva Pharmaceutical Industries Ltd.

What will be the Upper Respiratory Tract Infection Treatment Market Size in 2020?

Browse TOC and LoE with selected illustrations and example pages of Upper Respiratory Tract Infection Treatment Market

Request a FREE sample now!

Who are the Major Upper Respiratory Tract Infection Treatment Vendors?

The market is concentrated. The key vendors in the market are focusing on R&D and M&A activities to increase their market revenue and expand their regional base. AstraZeneca Plc, CSL Ltd., and GlaxoSmithKline Plc are some of the major market participants. vendors are focusing on the production of biologics to treat and manage symptoms of upper respiratory tract infection effectively. Although the rising demand for over-the-counter drugs will offer immense growth opportunities, the side effects of NSAIDs will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market position, this upper respiratory tract infection treatment market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market's competitive landscape and offers information on the products offered by various companies. Moreover, this upper respiratory tract infection treatment market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading companies, including:

• AstraZeneca Plc
• CSL Ltd.
• GlaxoSmithKline Plc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

Which are the Key Markets for Upper Respiratory Tract Infection Treatment?

For more insights on the market share of various regions Request for a FREE sample now!

North America was the largest upper respiratory tract infection treatment market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The increasing prevalence of upper respiratory tract infections and the rising demand for over-the-counter drugs will significantly drive upper respiratory tract infection treatment market growth in this region over the forecast period.

45% of the market's growth will originate from North America during the forecast period. The US is the key market for upper respiratory tract infection treatment in North America. Market growth in this region will be slower than the growth of the market in APAC.

What are the Major Type Segments in the Upper Respiratory Tract Infection Treatment Market?

Request for a FREE sample and Get more information on the market contribution of various segments

The antibiotics segment includes antibiotics such as azithromycin, amoxicillin, doxycycline, clarithromycin, erythromycin, and VIBRAMYCIN. The easy availability of antibiotics to treat upper respiratory tract infections and their symptoms will drive the upper respiratory tract infection treatment market growth during the forecast period. 

The upper respiratory tract infection treatment market share growth by the antibiotics segment will be faster than the growth of the market by the other segments. This report provides an accurate prediction of the contribution of all the segments to the growth of the upper respiratory tract infection treatment market size.

How will Over-the-counter Drugs Influence Upper Respiratory Tract Infection Treatment Market Growth?

The demand for over-the-counter drugs for upper respiratory tract infection treatment is increasing. Over-the-counter drugs do not require a written prescription from a health professional and can be directly purchased from the pharmacy. Cough suppressants, nasal decongestants, and nasal washes are easily available from the pharmacy as over-the-counter drugs. The increasing availability of over-the-counter drugs for the treatment of upper respiratory tract infection will also promote the practice of self-medication among individuals. The rising demand for over-the-counter drugs is a significant factor that will fuel upper respiratory tract infection treatment market growth at a CAGR of over 3% during the forecast period.

• The high efficacy and fewer complications associated with biologics have boosted their popularity for the treatment of upper respiratory tract infections.
• A biologic therapy known as omalizumab has exhibited promising results for the treatment of both allergic and non-allergic variants of chronic rhinosinusitis with nasal polyps.
• Omalizumab binds to the free-circulating immunoglobulin E to minimize its expression on mast cells, basophils, and dendritic cells and consequently interfere with the activation of these effector cells.
• The growing popularity of biologics has been identified as one of the critical upper respiratory tract infection treatment market trends, which will positively influence the growth of the market during the forecast period.

Request for a FREE sample now!

What are the Key Factors Covered in this Upper Respiratory Tract Infection Treatment Market Report?

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will drive upper respiratory tract infection treatment market growth during the next five years
• Precise estimation of the upper respiratory tract infection treatment market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the upper respiratory tract infection treatment industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of upper respiratory tract infection treatment market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch